nationwide semaglutide In a Danish study, just over half of adults without diabetes who started for weight loss discontinued within a year. Discontinuation was highest among younger adults (18–30 years), men, those Type 2 diabetes: New Ozempic
Description
Its FDA-approved for weight loss in people with obesity or overweight and have a weight-related health issue, like type 2 diabetes or high blood pressure
elik AF, Oar Z, Damci T, Pamuk N, Pamuk GE, lkova H
Finally, the GlP-1 receptor may be associated with triiodothyronine (T3) levels
The Lancet Diabetes & Endocrinology, 11(1), 3341
Like other GLP-1 medications, semaglutide can cause side effects such as gastrointestinal symptoms and potentially serious risks described in its prescribing information, so it should only be used under the guidance of a licensed healthcare provider
